Global Coronary Artery Bypass Graft Market Size, Share, Forecast Report, 2020-2027

Coronary artery bypass grafting (CABG) is a type of bypass surgery that is used to create a new path for blood to flow to the heart. This is used for patients who have severe coronary heart disease. CABG is the most common type of open heart surgery in the United States. Deskbound lifestyle, anxiety, stress and high consumption of junk food are key reasons that causes cardiovascular diseases in individuals around the globe. The market for coronary artery bypass graft is growing rapidly. The credit of this high growth can be given to increasing number of cases of cardiovascular disease which is the result of changing lifestyle along with it increase in patient’s awareness about this disease, related surgeries and therapies.

The global market for coronary artery bypass graft is expected to reach around USD 116 million by the end of the forecast period and is expected to grow at the CAGR of ~6.0%.
Key Players for Global Coronary Artery Bypass Graft Market:

Some of the key players in this market are: Hancock Jaffe Laboratories, Inc., Terumo Cardiovascular Systems Corporation, VasoPrep Surgical, Dextera Surgical Inc., Neograft Inc., NOVADAQ Technologies Inc., MAQUET Holding B.V. & Co. KG., Genesee BioMedical, Sorin Group, Edwards Lifesciences Corporation and others.

Segments:

Global coronary artery bypass graft market has been segmented on the basis of type which comprises of off-pump, on-pump, minimally invasive direct CABG, endoscopic vein harvesting and others. On the basis of procedure; the market is segmented into single CABG surgery, double CABG surgery, triple CABG surgery, quadruple CABG surgery and others. On the basis of end users the market is segmented into hospitals, cardiology clinics, research institutes and others.